NCT06028568

Brief Summary

This study aimed to analyze the reliability and validity of the results of the new designed perioperative cognitive test network platform, and to judge the reliability and scientific nature of the perioperative cognitive test. And then to explore whether the perioperative cognitive test network platform can be used to evaluate the changes of perioperative cognitive function of patients.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Oct 2023

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 7, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 8, 2023

Completed
23 days until next milestone

Study Start

First participant enrolled

October 1, 2023

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2024

Completed
Last Updated

September 14, 2023

Status Verified

June 1, 2023

Enrollment Period

3 months

First QC Date

July 7, 2023

Last Update Submit

September 13, 2023

Conditions

Outcome Measures

Primary Outcomes (2)

  • Reliability

    Cronbach's alpha is used to assess the reliability and the internal consistency of this Cognitive test. Cronbach's alpha value \>0.7 indicating the reliability of the test is acceptable.

    Baseline Test:1 day before operation, Second Test: Day 7 after operation

  • Validity

    Content validity, Construct validity and Responsiveness analysis are used to evaluate the validity of the cognitive test. The item-content validity index (I-cvi) is used evaluate the Content validity. I-cvi≥ 0.78 means the content validity is satisfactory. The Exploratory Factor Analysis (EFA) is used evaluate the Construct validity. The Kaiser-Mayer-Olkin (KMO) index (\>0.6) is used to evaluate adaptability for factor analysis. Factor loading should \>0.4. The Responsiveness analysis is used to evaluate the ability of this cognitive test that can reflect the change of cognitive function of the Interviewer during operation. Paired t-test can be used to compare whether the difference in score before and after is statistically significant. P value should \< 0.05.

    Baseline Test:1 day before operation, Second Test: Day 7 after operation

Secondary Outcomes (1)

  • PND (Perioperative neurocognitive disorders)

    Baseline Test:1 day before operation, Second Test: Day 7 after operation

Study Arms (2)

Elderly patients undergoing surgery

Older than or equal to 65 years of age; patients who intend to undergo major abdominal surgery under general anesthesia (grade 3-4 surgery based on surgical grade)

Elderly healthy volunteers

Age-and sex-matched community population

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

This study will include two groups: elderly healthy volunteers and elderly patients undergoing abdominal surgery.

You may qualify if:

  • Age over 65
  • Scheduled for abdominal surgery under general anesthesia (grade 3-4 surgery based on surgical grade)
  • Informed consent has been obtained
  • Healthy volunteer groups are listed as age-and sex-matched community groups

You may not qualify if:

  • Unable to follow instruction and finish the firtst procedure
  • Has severe visual or auditory problems
  • History of drug or alcohol abuse (drinking more than 5U daily in the past 3 months, 1U equals 10ml or 8g pure alcohol, equivalent to \>50 liquor over 100ml, two two
  • Are diagnosed neuropsychological disease that needs treatment
  • Clear history of severe cerebrovascular diseases (including cerebral hemorrhage and cerebral infarction), Parkinson's syndrome, schizophrenia, bipolar disorder, depression, dementia, Alzheimer's disease, etc
  • Severe head trauma, carbon monoxide poisoning and other loss of consciousness more than 30 minutes
  • MMSE score ≤23
  • Participated this study or being participating other clinical research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Zhixin Wu, physician

CONTACT

Study Design

Study Type
observational
Observational Model
ECOLOGIC OR COMMUNITY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 7, 2023

First Posted

September 8, 2023

Study Start

October 1, 2023

Primary Completion

December 31, 2023

Study Completion

March 31, 2024

Last Updated

September 14, 2023

Record last verified: 2023-06